Using the similarity factor f2 in practice: A critical revision and suggestions for its standard error estimation
暂无分享,去创建一个
Jordi Ocaña | G. Frutos | O PilarSánchez | J. Ocaña | G. Frutos | O. PilarSánchez | Gloria Frutos | Pilar Sánchez O
[1] G. Frutos,et al. Nonlinear mixed-effects model for the dissolution assays of drugs. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[2] C. Goodman. United States Pharmacopeial Convention , 1988 .
[3] Svetlana Ibrić,et al. The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[4] Yi Tsong,et al. In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2 , 1998, Pharmaceutical Research.
[5] K. Pathak,et al. Osmotic flow through asymmetric membrane: A means for controlled delivery of drugs with varying solubility , 2006, AAPS PharmSciTech.
[6] Beom-Jin Lee,et al. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[7] M. A. Holgado,et al. In vitro evaluation of a morphine polymeric complex: Flowability behavior and dissolution study , 2004, AAPS PharmSciTech.
[8] J. Parojčić,et al. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance , 2008, AAPS PharmSciTech.
[9] Michael Levin. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .
[10] Yi Lu,et al. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] Henry H. Flanner,et al. Dissolution Fit Factors as Response Variables in Statistically Designed Experiments , 2001 .
[12] M. Patel,et al. Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation , 2004, AAPS PharmSciTech.
[13] J. W. Moore,et al. Mathematical comparison of dissolution profiles , 1996 .
[14] Wendy I. Wilson,et al. Comparison of statistical analysis and Bayesian Networks in the evaluation of dissolution performance of BCS Class II model drugs. , 2005, Journal of pharmaceutical sciences.
[15] Shein-Chung Chow. Encyclopedia of Biopharmaceutical Statistics , 2010 .
[16] Jinhe Li,et al. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia apparatus II and III , 2002, AAPS PharmSciTech.
[17] Gudrun Freitag,et al. Guidelines on Dissolution Profile Comparison , 2001 .
[18] M. Gohel,et al. Refinement of Lower Acceptance Value of the Similarity Factor f2 inComparison of Dissolution Profiles , 2002 .
[19] V. Kadam,et al. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride , 2007, AAPS PharmSciTech.
[20] S. Chow,et al. Statistical Evaluation of Similarity Factor f_2 as a Criterion for Assessment of Similarity Between Dissolution Profiles , 1997 .
[21] M. Gohel,et al. Assessment of Similarity Factor Using Different Weighting Approaches , 2005 .
[22] D. Patel,et al. Floating granules of ranitidine hydrochloride-gelucire 43/01: Formulation optimization using factorial design , 2007, AAPS PharmSciTech.
[23] J. Liu,et al. ASSESSMENT OF SIMILARITY BETWEEN DISSOLUTION PROFILES* , 2000, Journal of biopharmaceutical statistics.